Is Ambu A/S (AMBBY) a Buy, Sell, or Hold?
OTC : AMBBY
Ambu A/S
$10.51 USD
$0.81 (8.35%)
- Volume
- 1K
- Average Volume
- 145
- Market Capitalization
- $2.79B
- P/E Ratio
- 39.04
- Dividend Yield
- 0.59%
- Price Target
- Year High
- $16.78
- Year Low
- $8.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.23
- Current Ratio
- $2.92
Company Overview
OTC
Britt Meelby Jensen
Medical - Devices
Healthcare
AMBBY
5292
DK
USD
Liquidity Metrics
0.09
2.92
1.73
0.67
0.23
Sales & Valuation
$5.69B
3.03
3.04
35.80
1.94
Profitability
$2.15
$573.61M
7.81%
10.16%
7.92%
6.27%
P/E Metrics
39.04
1.35
1.35
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
5.93
5/9
$1.98B
$7.61B
$1.51B
$667.36M
Key Metrics (TTM)
$18.8B
3.08
18.09
2.92
7.92%
7.56%
2.51%
2.72%
$30.36
154 days
Company Executives
| Name | Title |
|---|---|
| Jesper Johnsen Steen | Chief Marketing Officer |
| Tine Bjorn Schmidt | Head of Corporate Communications |
| Finn Mohring | Chief Technology Officer |
| Sanne Kjærsgaard Hjordrup | Chief People & Culture Officer |
| Holger Hesse | Founder |
| Thomas Lykke Henriksen | Head of HR Systems |
| Anders Hjort | Head of Investor Relations |
| Henrik Skak Bender | Chief Financial Officer |
| Britt Meelby Jensen | Chief Executive Officer |
| Graziela Chaluppe dos Santos Malucelli | Chief Operations Officer |
Poll Results
No votes yet today — be the first to share your view!
About Ambu A/S (OTC:AMBBY) Stock
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark. ...
Frequently Asked Questions
-
What is the current Ambu A/S (AMBBY) stock price?
-
Ambu A/S(OTC:AMBBY) stock price is $10.51 in the last trading session. During the trading session, AMBBY stock reached the peak price of $16.78 while $8.545 was the lowest point it dropped to. The percentage change in AMBBY stock occurred in the recent session was 8.35% while the dollar amount for the price change in AMBBY stock was $0.81.
-
AMBBY's industry and sector of operation?
-
The OTC listed AMBBY is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of AMBBY?
-
Jesper Johnsen Steen | Chief Marketing Officer
Tine Bjorn Schmidt | Head of Corporate Communications
Finn Mohring | Chief Technology Officer
Sanne Kjærsgaard Hjordrup | Chief People & Culture Officer
Holger Hesse | Founder -
How many employees does AMBBY have?
-
Number of AMBBY employees currently stands at 5292. AMBBY operates from Baltorpbakken 13, Ballerup, CR 2750, DK.
-
Link for AMBBY official website?
-
Official Website of AMBBY is: https://www.ambu.com
-
How do I contact AMBBY?
-
AMBBY could be contacted at phone #45 72 25 20 00 and can also be accessed through its website. AMBBY operates from Baltorpbakken 13, Ballerup, CR 2750, DK.
-
How many shares of AMBBY are traded daily?
-
The average number of AMBBY shares traded daily for last 3 months was 145.
-
What is the market cap of AMBBY currently?
-
The market value of AMBBY currently stands at $2.79B with its latest stock price at $10.51